Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1964 May;17(3):287–291. doi: 10.1136/jcp.17.3.287

The laboratory control of thrombolytic therapy

Christine Hawkey 1, Margaret Howell 1
PMCID: PMC480744  PMID: 14159462

Abstract

Methods are described by which thrombolytic therapy with local and systemic infusion of streptokinase can be initiated and controlled.

Full text

PDF
287

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. The mechanism of clot dissolution by plasmin. J Clin Invest. 1959 Jul;38(7):1086–1095. doi: 10.1172/JCI103885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BUCKELL M. The effect of citrate on euglobulin methods of estimating fibrinolytic activity. J Clin Pathol. 1958 Sep;11(5):403–405. doi: 10.1136/jcp.11.5.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DENSON K. W. The specific assay of Prower-Stuart factor and factor VII. Acta Haematol. 1961 Feb;25:105–120. doi: 10.1159/000206523. [DOI] [PubMed] [Google Scholar]
  4. DISCHE F. E., BENFIELD V. Congenital factor VII deficiency: haematological and genetic aspects. Acta Haematol. 1959 May;21(5):257–271. doi: 10.1159/000205700. [DOI] [PubMed] [Google Scholar]
  5. FEARNLEY G. R., BALMFORTH G., FEARNLEY E. Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis. Clin Sci. 1957 Nov;16(4):645–650. [PubMed] [Google Scholar]
  6. FLETCHER A. P., ALKJAERSIG N., SHERRY S. The maintenance of a sustained thrombolytic state in man. I. Induction and effects. J Clin Invest. 1959 Jul;38(7):1096–1110. doi: 10.1172/JCI103886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HAWKEY C., HOWELL M. INTRAVENOUS STREPTOKINASE IN THE TREATMENT OF RETINAL VASCULAR OCCLUSION. J Clin Pathol. 1964 May;17:363–364. doi: 10.1136/jcp.17.3.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HOWELL M. A method for the comparison of the antiplasmin activity of two groups of blood sera. J Clin Pathol. 1963 May;16:289–290. doi: 10.1136/jcp.16.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. JOHNSON A. J., McCARTY W. R. The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase. J Clin Invest. 1959 Sep;38:1627–1643. doi: 10.1172/JCI103941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. NIEWIAROWSKI S., KOWALSKI E. Unnouvel anticoagulant dérivé du fibrinogène. Rev Hematol. 1958 Jul-Sep;13(3):320–328. [PubMed] [Google Scholar]
  11. NILSSON I. M., OLOW B. Determination of fibrinogen and fibrinogenolytic activity. Thromb Diath Haemorrh. 1962 Nov 15;8:297–310. [PubMed] [Google Scholar]
  12. RATNOFF O. D., MENZIE C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med. 1951 Feb;37(2):316–320. [PubMed] [Google Scholar]
  13. REMMERT L. F., COHEN P. P. Partial purification and properties of a proteolytic enzyme of human serum. J Biol Chem. 1949 Nov;181(1):431–448. [PubMed] [Google Scholar]
  14. STEFANINI M. Activity of plasma labile factor in disease. Lancet. 1951 Mar 17;1(6655):606–610. doi: 10.1016/s0140-6736(51)91115-4. [DOI] [PubMed] [Google Scholar]
  15. TILLETT W. S., JOHNSON A. J., McCARTY W. R. The intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients. J Clin Invest. 1955 Feb;34(2):169–185. doi: 10.1172/JCI103071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. WOLF P. A modification for routine laboratory use of Stefanini's method of estimating factor V activity in human oxalated plasma. J Clin Pathol. 1953 Feb;6(1):34–38. doi: 10.1136/jcp.6.1.34. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES